Professor Sir Nicholas White OBE KCMG FRS
3 February 2026
The University of Oxford and the Nuffield Department of Medicine greatly mourn the death of Professor Sir Nicholas White, a distinguished clinician and scientist who was internationally recognised as the leading figure in improving the treatment of malaria worldwide, and whose work has made a lasting contribution to global health research - saving millions of lives worldwide. Our thoughts are with his family at this time.
Long-overlooked cerebral cortical cell layer may hold key to attention
2 February 2026
Berlin and Oxford collaborative researchers funded by Einstein Foundation propose a new circuit theory linking a little-known cortical layer to attention and brain disorders.
National Perinatal Epidemiology Unit officially joins the Nuffield Department of Women’s & Reproductive Health
2 February 2026
The University of Oxford is pleased to announce that, as of Monday 2 February, the National Perinatal Epidemiology Unit (NPEU) has officially joined the Nuffield Department of Women’s & Reproductive Health (NDWRH). This marks a significant milestone in a partnership first announced in 2025 and represents a major strategic step in strengthening Oxford’s leadership in women’s, maternal and reproductive health research and education.
Oxford spinout launches AI-based ultrasound technology to improve early detection of pregnancy complications
2 February 2026
A new University of Oxford spinout, Oxailis Ltd, has launched an AI-based ultrasound technology that enables healthcare professionals to measure perfusion (how effectively oxygen-rich blood is delivered to tissue), using existing standard ultrasound hardware and without the need for contrast agents.
Study tests whether deep brain stimulation can treat chronic pain
2 February 2026
A research study by Oxford neurosurgeons and engineers is trialling whether deep brain stimulation (DBS) – delivering an electrical pulse into affected areas of the brain – can help to relieve central post-stroke pain (CPSP).
Who gets menopause treatment – and who is left out?
30 January 2026
Hormone replacement therapy (HRT) is one of the most effective treatments for menopausal symptoms, yet a major new international study led by researchers from the Nuffield Department of Primary Care Health Sciences suggests that access to it is far from equal.
Oxford academics among the first Fellows of the Academy for the Mathematical Sciences
30 January 2026
Twelve Oxford academics have been appointed to the Academy for the Mathematical Sciences’ inaugural cohort of Fellows, which will bring together the UK’s strongest mathematicians across academia, education, business, industry, and government to help solve some of the UK’s biggest challenges.
A step forward for ankle fracture management
29 January 2026
In an editorial piece published in The BMJ, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professors David Keene and Matthew Costa commend a new clinical trial that advances the understanding of ankle fracture treatment.
Kennedy scientists join world-leading researchers in ‘pivotal’ study to help arthritis patients to live drug free
27 January 2026
The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration.
Reducing salt in everyday foods could prevent tens of thousands of heart attacks and strokes, new study finds
26 January 2026
A new study led by researchers in the Nuffield Department of Primary Care Health Sciences has found that if the UK food industry had met the government’s voluntary 2024 salt reduction targets, substantial improvements could have been made in cardiovascular health, leading to major savings for the NHS - all without the public having to change their eating habits.
Rapamycin helps protect immune cells against DNA damage
26 January 2026
New research carried out by Dr Loren Kell at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has demonstrated for the first time that rapamycin can reduce DNA damage in immune cells, a hallmark of ageing.
Convoluted systems block access to GP appointments
23 January 2026
Centrally imposed systems for booking GP appointments and the effort needed to keep them working to improve access for patients is having the opposite effect, according to new research led by the Universities of Oxford and Southampton.
NDORMS and NDCN collaborate with Oxford University Hospitals to form the Kadoorie Institute for Trauma, Emergency and Critical Care
23 January 2026
Oxford Trauma and Emergency Care at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), along with the Critical Care Research Team at Nuffield Department of Clinical Neurosciences (NDCN) have formally become a new Institute within the University of Oxford: the Kadoorie Institute for Trauma, Emergency and Critical Care.
Number 1 for the 15th consecutive year
22 January 2026
The University of Oxford has been ranked first in the world by Times Higher Education (THE) Subject Rankings for Medicine and Health, making it the 15th consecutive year for Oxford to lead in the medical sciences.
Oxford researchers join Novo, Gates, and Wellcome to tackle antimicrobial resistance
22 January 2026
Oxford researchers from the Nuffield Department of Medicine are part of a major new international initiative with the Novo Nordisk Foundation, Wellcome and the Gates Foundation to accelerate the discovery of urgently needed antibiotics. The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) brings together global expertise to tackle drug-resistant Gram-negative infections, one of the most serious threats to global health.
Attention-Deficit Hyperactivity Disorder (ADHD) medication use rises sharply across Europe, driven by growth among adults
22 January 2026
The use of medications for ADHD has increased substantially across Europe over the past decade, with the steepest rises seen among adults - particularly women - according to a large population-based study published in The Lancet Regional Health - Europe.
From the margins to many: Designing mental health systems that young people can truly trust
21 January 2026
How can we build systems that adolescents trust enough to speak honestly, and that are safe enough to receive what they say?
Oxford launches AI Cancer Scientist to accelerate cancer vaccine discovery
20 January 2026
The University of Oxford has launched the AI Cancer Scientist, a first-of-its-kind research project exploring whether a closed loop system using artificial intelligence and automation can significantly speed up the early stages of cancer vaccine discovery, supported by funding from the Advanced Research and Invention Agency (ARIA).
Study suggests blood pressure care after giving birth could protect brain health
19 January 2026
Women who develop high blood pressure during pregnancy may be able to protect their long term brain health through better blood pressure management soon after giving birth, according to a new study by Oxford researchers.
New study highlights global impact of Oxford’s graduate global surgery course
15 January 2026
Oxford University Global Surgery Group has published a new paper in Global Surgical Education (Springer Nature), showcasing the impact and global reach of its Global Surgery Short Course. Titled ‘Perspectives and impact of a graduate global surgery course’, the paper offers valuable insights into the course’s role in shaping careers and advancing surgical care worldwide.